While the fragmented response offers a glimmer of hope to Pfizer, AstraZeneca also contends that under British takeover law, its hands are tied unless a third part steps in with a competing bid.
via NYT > Business Day http://ift.tt/1lR01zl
via WordPress http://ift.tt/1mZaj3d
via All Business Is Good Business http://ift.tt/1jtbd6W
via WordPress http://ift.tt/1lRfEXC
0 comments:
Post a Comment